Advertisement
Advertisement
U.S. markets open in 8 hours
Advertisement
Advertisement
Advertisement
Advertisement

CSPC Pharmaceutical Group Limited (1093.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
7.670-0.130 (-1.67%)
As of 01:15PM HKT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/1/2022
Current
Market Cap (intraday)
92.84B
Enterprise Value
78.82B
Trailing P/E
15.48
Forward P/E
11.98
PEG Ratio (5 yr expected)
1.69
Price/Sales (ttm)
2.88
Price/Book (mrq)
3.04
Enterprise Value/Revenue
2.66
Enterprise Value/EBITDA
11.40

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-14.19%
S&P500 52-Week Change 3-13.12%
52 Week High 310.100
52 Week Low 36.950
50-Day Moving Average 37.948
200-Day Moving Average 38.335

Share Statistics

Avg Vol (3 month) 328.99M
Avg Vol (10 day) 330.36M
Shares Outstanding 511.93B
Implied Shares Outstanding 6N/A
Float 88.36B
% Held by Insiders 129.56%
% Held by Institutions 133.22%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.2
Forward Annual Dividend Yield 42.56%
Trailing Annual Dividend Rate 30.17
Trailing Annual Dividend Yield 32.13%
5 Year Average Dividend Yield 41.38
Payout Ratio 432.80%
Dividend Date 3N/A
Ex-Dividend Date 4Sep 08, 2022
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 18.58%
Operating Margin (ttm)22.37%

Management Effectiveness

Return on Assets (ttm)11.57%
Return on Equity (ttm)20.49%

Income Statement

Revenue (ttm)29.65B
Revenue Per Share (ttm)2.48
Quarterly Revenue Growth (yoy)9.10%
Gross Profit (ttm)21.14B
EBITDA 7.41B
Net Income Avi to Common (ttm)5.51B
Diluted EPS (ttm)0.510
Quarterly Earnings Growth (yoy)-1.80%

Balance Sheet

Total Cash (mrq)13.97B
Total Cash Per Share (mrq)1.17
Total Debt (mrq)682.56M
Total Debt/Equity (mrq)2.32
Current Ratio (mrq)2.70
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)6.15B
Levered Free Cash Flow (ttm)3.01B
Advertisement
Advertisement